Poseida Therapeutics

Brent Warner, President, Gene Therapy  

Oct. 12 | 5:00pm | UBC Ballroom  

San Diego, CA 

(NASDAQ: PSTX) 

In-person Presentation 

Poseida Therapeutics is a clinical-stage biopharmaceutical company dedicated to utilizing its proprietary gene engineering platform technologies to create next generation cell and gene therapeutics with the capacity to cure. The company has discovered and is developing a broad portfolio of product candidates in a variety of indications based on its core proprietary platforms, including its non-viral piggyBac DNA Modification System, Cas-CLOVER site-specific gene editing system, and nanoparticle- and AAV-based gene delivery technologies. Poseida’s core platform technologies have utility, either alone or in combination, across many cell and gene therapeutic modalities and enable the company to engineer its portfolio of product candidates that are designed to overcome the primary limitations of current generation cell and gene therapeutics. 

www.poseida.com 



By using this website you agree to accept our Privacy Policy and Terms & Conditions